What is Steel Partners' offer price for InMode and how does it compare to the CEO buyout?

Steel Partners bid $16.75 per share in an unsolicited cash offer to acquire InMode. The article does not disclose the CEO-led proposal price, but the competing bids indicate investor disagreement over the company's valuation and strategic direction.

What InMode devices are most used in medspas and how could a buyout affect them?

Morpheus8 (fractional RF microneedling), Lumenis Ultra (diode laser), and Forma (monopolar RF) are InMode's core franchises with significant installed bases across North American medspas and dermatology practices. The acquisition outcome will likely shape access terms, pricing, and service support for practices currently using these devices.

Why is Steel Partners making an unsolicited bid for InMode?

Steel Partners is an activist investor signaling pressure on InMode's valuation and strategic direction. The competing bids reflect broader investor appetite for consolidated device platforms, especially as medical practices and MSOs scale and consolidate.

How could InMode's acquisition affect medspas and dermatology practices?

The acquisition outcome will directly impact device access, pricing, and service support for practices currently running InMode equipment. Consolidation of device platforms under a new owner could reshape terms and availability for medspas relying on Morpheus8, Lumenis Ultra, and Forma devices.

What does an unsolicited bid mean for InMode shareholders and the company's future?

An unsolicited bid means Steel Partners is offering to buy InMode without management approval, creating a competing offer against the CEO-led buyout proposal. This puts pressure on the board to evaluate both offers and determine which best serves shareholder interests.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Business & M&A

Steel Partners Bids $16.75 Per Share for InMode — Unsolicited Offer Challenges CEO Buyout

Activist investor Steel Partners launches rival cash offer for the RF microneedling and energy-device maker.

By Evan at Inside MedSpa · Jul 10, 2026

1-YEAR MOVE

INMD ▲1.0%

1-year price move by ticker
Ticker	Company	1-year change
INMD	InMode Ltd.	+1.0%

Steel Partners Holdings has made an unsolicited cash offer of $16.75 per share to acquire InMode Ltd., the Israeli-listed RF microneedling and energy-device manufacturer. The bid directly challenges a competing CEO-led buyout proposal and signals activist pressure on the company's valuation and strategic direction.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/steel-partners-inmode-16-75-bid/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

Steel Partners Bids $16.75 Per Share for InMode — Unsolicited Offer Challenges CEO Buyout

Share

Discussion

Leave a comment

By the time it's news, it's too late.